[On the biosynthesis of nicotine].

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85

Mind reading: neural mechanisms of theory of mind and self-perspective. Neuroimage (2001) 3.03

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care (1997) 2.63

Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care (1997) 2.32

The Hamilton scales and the Hopkins Symptom Checklist (SCL-90). A cross-national validity study in patients with panic disorders. Br J Psychiatry (1992) 2.16

Net costs of dementia by disease stage. Acta Psychiatr Scand (2011) 2.11

Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07

TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry (2010) 2.00

Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet (1999) 1.98

Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res (1998) 1.95

Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry (2001) 1.84

Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83

Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology (2012) 1.78

Risk factors for incident mild cognitive impairment--results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe). Acta Psychiatr Scand (2009) 1.76

Pharmacokinetic disposition of quinolones in human body fluids and tissues. Clin Pharmacokinet (1989) 1.67

Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry (1997) 1.66

Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry (2011) 1.65

A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann Neurol (2000) 1.61

Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry (2004) 1.60

Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry (1999) 1.59

Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57

Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on Psychological Problems in General Health Care. Br J Psychiatry Suppl (1998) 1.57

Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med (2012) 1.56

Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55

A congenital teratoma with a cleft palate: report of a case. Br J Oral Maxillofac Surg (2005) 1.50

Essential functions of the human self model are implemented in the prefrontal cortex. Conscious Cogn (1999) 1.48

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med (2011) 1.45

A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry (2000) 1.45

Risk factors for new depressive episodes in primary health care: an international prospective 12-month follow-up study. Psychol Med (2002) 1.44

The plant sterol brassicasterol as additional CSF biomarker in Alzheimer's disease. Acta Psychiatr Scand (2011) 1.43

Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder. Mol Psychiatry (2011) 1.43

A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet (2001) 1.42

Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry (2011) 1.40

[Chondrosarcoma of the larynx. Experience gained in Freiburg since 1999]. HNO (2011) 1.40

[Infant mortality, age of the mothers and number of children]. Arch Gynakol (1965) 1.39

[Encephalopathy following poisoning with an anticholinergic agent]. Dtsch Med Wochenschr (1994) 1.39

Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry (2006) 1.38

[Psychiatric diseases and their treatment in general practice in Germany. Results of a World Health Organization (WHO) study]. Nervenarzt (1996) 1.38

An economic model of the long-term health care burden of Type II diabetes. Diabetologia (2001) 1.37

Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology (2004) 1.36

Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis". J Psychiatr Res (2000) 1.34

Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry (2005) 1.34

Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers. Antimicrob Agents Chemother (2007) 1.33

Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut (1986) 1.32

Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med (2007) 1.31

Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry (2008) 1.28

Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry (2004) 1.18

Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing. Exp Neurol (2009) 1.17

Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry (2002) 1.14

Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. Pharmacogenomics J (2010) 1.14

Fragile-X carrier females: evidence for a distinct psychopathological phenotype? Am J Med Genet (1996) 1.12

High neuroticism and depressive temperament are associated with dysfunctional regulation of the hypothalamic-pituitary-adrenocortical system in healthy volunteers. Acta Psychiatr Scand (2004) 1.11

Human amygdala reactivity is diminished by the β-noradrenergic antagonist propranolol. Psychol Med (2010) 1.10

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann Neurol (1999) 1.10

International trends in admissions and drug sales for asthma. Int J Tuberc Lung Dis (2006) 1.10

Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am J Hum Genet (1998) 1.09

Neuropeptide S receptor gene -- converging evidence for a role in panic disorder. Mol Psychiatry (2010) 1.09

Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med (2008) 1.09

Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry (2004) 1.08

Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene. Transl Psychiatry (2014) 1.07

Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry (1998) 1.07

Foreseeing complications of coronary angioplasty--predicting the unpredictable. Eur Heart J (1999) 1.07

Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am J Med Genet (2001) 1.05

A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. Neurology (2009) 1.05

Molecular cloning and heterologous expression of acridone synthase from elicited Ruta graveolens L. cell suspension cultures. Plant Mol Biol (1995) 1.05

Effect of antacid medication on the pharmacokinetics of temafloxacin. Clin Pharmacokinet (1992) 1.05

Genome-wide association analysis of copy number variation in recurrent depressive disorder. Mol Psychiatry (2011) 1.05

Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment. J Nutr Health Aging (2009) 1.04

Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. Neuroreport (2000) 1.04

Effect of cimetidine on the pharmacokinetics of temafloxacin. Clin Pharmacokinet (1992) 1.03

Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry Suppl (2007) 1.02

Trends and geographical variation of primary hip and knee joint replacement in Germany. Osteoarthritis Cartilage (2012) 1.02

Estimating the heritability of reporting stressful life events captured by common genetic variants. Psychol Med (2012) 1.01

Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14. Mol Psychiatry (2006) 1.01

The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression: results of a controlled family study. Acta Psychiatr Scand (1993) 1.01

Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet (1998) 1.01

[Etiology and therapy of the internal jugular vein thrombosis]. Laryngorhinootologie (2004) 1.01

Investigations on electrolyte concentrations in the nails of cystic fibrosis patients and controls. Bibl Paediatr (1967) 1.01

Results of a genome-wide genetic screen for panic disorder. Am J Med Genet (1998) 1.01

Cystic fibrosis detection by means of a test-strip. Pediatrics (1975) 1.00

Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Neurosci Lett (2004) 1.00

Cognitive functioning and anhedonia in subjects at risk for schizophrenia. Schizophr Res (1993) 1.00

Treatment monitoring and response prediction with proton MR spectroscopy in AD. Neurology (2006) 1.00

The European registry of cardiac catheter interventions 1996. Eur Heart J (2001) 1.00

Assessing cognitive changes in the elderly: reliable change indices for the Mini-Mental State Examination. Acta Psychiatr Scand (2012) 0.99

Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms. Mol Psychiatry (2009) 0.99

Depressive disorder moderates the effect of the FTO gene on body mass index. Mol Psychiatry (2011) 0.98

[Mental disorders in the general population : Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)]. Nervenarzt (2014) 0.98

Multicenter linkage study of schizophrenia loci on chromosome 22q. Mol Psychiatry (2004) 0.98

Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits. Neuroscience (2005) 0.98

Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet (1996) 0.98

[Potentially inappropriate medication in elderly primary care patients : A retrospective, longitudinal analysis]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2013) 0.98

[Malignant rhino- and otobasal mucosal melanomas--therapy and outcome]. Laryngorhinootologie (2008) 0.98

Familial occurrence of tardive dyskinesia. Acta Psychiatr Scand (2001) 0.97

Support for the association between the rare functional variant I425V of the serotonin transporter gene and susceptibility to obsessive compulsive disorder. Mol Psychiatry (2005) 0.97

Coronary computed tomography angiography indicates complexity of percutaneous coronary interventions. J Invasive Cardiol (2012) 0.97

Clinical subtypes in panic disorder: their descriptive and prospective validity. J Affect Disord (1987) 0.97

Rotational tomography of the normal and reconstructed middle ear in temporal bones: an experimental study. Eur Arch Otorhinolaryngol (2006) 0.97

Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state. Psychol Med (2008) 0.96